期刊文献+

紫杉醇对血管外膜成纤维细胞MAPK/ERK通路的影响

Effect of paclitaxel on vascular adventitial fibroblasts MAPK/ERK pathway
原文传递
导出
摘要 目的观察紫杉醇对血管外膜成纤维细胞MAPK/Erk通路的影响。方法选雄性SD大鼠,贴壁法培养胸主动脉外膜成纤维细胞并鉴定。以0,9 nmol.L-1紫杉醇分别干预,用Western Blot法,分别检测磷酸化ERK1/2的表达并进行比较。结果磷酸化ERK1/2的表达,在9 nmol.L-1较0 nmol.L-1紫杉醇明显降低;9 nmol.L-1紫杉醇组ERK蛋白的磷酸化水平为0 nmol.L-1紫杉醇组的62%(P<0.05)。结论紫杉醇通过抑制血管外膜成纤维细胞MAPK/ERK通路,能延缓冠脉动脉介入术后再狭窄。 Objective To study influence of paclitaxel on adventitial fibroblasts from MAPK/Erk pathway.Methods Adventitial fibroblast(AF) were prepared from rat aortas using explant technique and cultured for passages,0,9 nmol·L-1 paclitaxel respectively interventions,used Western Blot methods to respectively detect expression of phosphorylation of ERK1/2 then to compare and analysis.Results Phosphorylation of ERK1/2 expression of 9 nmol·L-1 paclitaxel group was significantly less than that of 0 nmol·L-1 paclitaxel group.The levels of 9 nmol·L-1 paclitaxel group on ERK1/2 phosphorylation express is 62% of paclitaxel 0 nmol·L-1 group(P〈0.05).Conclusion Paclitaxel can delay of restenosis after coronary artery intervention with inhibition vascular adventitial fibroblasts MAPK/ERK path.
机构地区 舟山医院心内科
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2012年第7期513-515,共3页 The Chinese Journal of Clinical Pharmacology
关键词 紫杉醇 血管外膜 PCI术后再狭窄 paclitaxel; vascular adventitial; restenosis after percutaneous coronary intervention
  • 相关文献

参考文献5

  • 1rruys PW, Degertekin M, Tanabe K, et al. Vaxcular response at proximal and distal edges of paclitaxel eluting stents : serial intravas- cular ultrasound analysis from the TAXUSII trial [ J]. Circulation, 2004 ; 109:627 - 633.
  • 2Ube E, Silber S, Hauptmann KE, et al. Six and twelve month re-suits from a randomized, double blind trial on a slow release pacilaxel eluting stent for de novo coronary lesions [ J ]. Circulation, 2003 ; 107:38 -42.
  • 3Liang Y, O'Driscoll L, McDonnell S, et al. Enhanced in vitro inva- siveness and drug resistance with altered gene expression patterns in a human lung carcinoma cell line after pulse selection with anticancer drugs[J]. Int J Cancer, 2004; 111:484 -493.
  • 4Stamenkovic I. Matrix metalloproteinases in tumor invasion and me- tastasis[ J]. Semin Cancer Biol, 2000 ; 10:415 -433.
  • 5Yang JM, Xu Z, Wu H, et al. Over expression of extracellular ma- trix metalloproteinase inducer in muhidrug resistant cancer cells [ J ]. Mol Cancer Res, 2003 ; 1:420 -427.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部